The
anti-viral medication Remdesivir is the first drug to get approval by the FDA to help fight SARS-CoV 2, the virus that causes COVID-19. For use in hospitalized patients only, preliminary data
shows those with advanced COVID-19 and lung involvement recovered faster after receiving Remdesivir.. It also shows activity in the lab and in animals against related coronaviruses including SARS
and MERS-Co-V.